3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
9
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
7
Wilms Tumor
1
Testicular Germ Cell Tumor
1
Prostate Cancer Metastatic
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic cancer, adult
1
Ovarian Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Kidney Neoplasms
1
Hepatic Veno-Occlusive Disease
1
Glioblastoma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
pembrolizumab
27
Docetaxel
20
Cyclophosphamide
18
Surveys and Questionnaires
15
Therapeutics
14
Radiotherapy
13
Paclitaxel
12
Psychiatric Rehabilitation
11
Early Intervention, Educational
11
Carboplatin
11
Standard of Care
10
olaparib
9
Zoledronic Acid
9
Specimen Handling
9
Radiosurgery
9
Magnetic Resonance Spectroscopy
9
Interviews as Topic
9
Gemcitabine
9
Trastuzumab
8
Methods
8
Fulvestrant
8
palbociclib
7
fludarabine
7
durvalumab
7
Taxes
7
Nivolumab
7
Fluorodeoxyglucose F18
7
Flow Cytometry
7
Educational Status
7
Blood Specimen Collection
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Hematologic Tests
×
Genitourinary
×
Clear all
NCT03284684
2025-12-01
Periop ctDNA
Centre Hospitalier Universitaire de NÄ«mes
Completed
30 enrolled